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Abstract 
Background 
CCAAT enhancer-binding protein beta (CEBPB) is a transcription factor shown necessary for 
macrophage mediated repair after muscle injury in mouse models. In humans, CEBPB expression in 
blood was strongly associated with muscle strength.  In this study we aimed to test whether CEBPB 
expression in blood in people is increased after exercise designed to induce muscle damage, and 
subsequent repair.  
Findings 
Sixteen healthy male volunteers undertook elbow flexor exercises designed to induce acute muscle 
micro-damage. Peripheral blood samples collected at baseline, and days 1, 2, 4 and 7 following 
exercise. Expression of CEBPB and related genes were analysed by qRT-PCR. Extent of muscle 
damage was determined by decline in maximal voluntary isometric torque and by plasma creatine 
kinase activity.  
Nine subjects had peak creatine kinase activity exceeding 10 000 U/I. In this subgroup, CEBPB 
expression was elevated from baseline to 2 days post exercise (a priori paired-samples t(1,8) = 3.72, p 
= 0.006). Related expression and selected cytokine changes after exercise did not reach significance.  
Discussion  
Exercise-induced muscle damage in humans may be followed by induction of CEBPB transcript 
expression in peripheral blood leukocytes. Associations between CEBPB expression in blood and 
muscle strength are consistent with the CEBPB dependent repair process following micro-injury 
reported in mouse models.    
Keywords: muscle strength, inflammation, CEBPB, macrophage, muscle damage, muscle repair   
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Introduction 
CCAAT/enhancer-binding protein-beta (C/EBP-β, encoded for by CEBPB mRNA), is a pleiotropic 
transcription factor which regulates several immune cell functions. C/EBP-β has been shown to be  
central to post injury muscle repair since CEBPB expression is markedly increased during 
macrophage differentiation towards an anti-inflammatory (M2) ‘repair’ phenotype that governs the 
integration of newly formed myoblasts into regenerating muscle tissue [1]. In a murine model of 
repair after a muscle injury,  deletion of cAMP response element-binding protein (CREB) binding 
sites in the C/EBP-β promoter (thereby reducing CEBPB expression) in macrophages prevented the 
transition to an M2 regrowth and repair phenotype and inhibited muscle regeneration, resulting in 
fibrosis and muscle fibre loss [2]. 
Following injury, skeletal muscle undergoes a program of regeneration. Satellite progenitor cells, 
proliferate as myoblasts, and fuse into myotubes at the site of damage, where they differentiate into 
fully regenerated muscle fibres [3]. This sequence is mediated by a cascade of myogenic regulatory 
factors, which are subject to signalling from resident or infiltrating macrophages, and systemic 
factors originating in T lymphocytes. The proliferative phase of myoblasts is promoted by pro-
inflammatory (M1) macrophages. Subsequently, alternatively activated M2macrophages stimulate 
myotube differentiation [4]. M2 signal induction is mediated by Th2 cytokines [5]. 
We have previously demonstrated that the expression of the CEBPB gene in blood was the most 
strongly transcript associated with grip strength in 698 mostly older people in the InCHIANTI study, 
in a transcriptome-wide analysis of human circulating blood leukocytes [6]. A potential mechanism 
explaining the strength-blood CEBPB association may be the role of C/EBP- in muscle regeneration 
following lifelong muscle stress, and injury [2].   
 
4 
 
 In the current study, we aimed to establish whether Exercise-Induced Muscle Damage (EIMD) in 
humans results in increases in CEBPB expression in blood consistent with CEBPB’s role in post-injury 
muscle repair.  We also tested whether blood  CEBPB and related expression and  plasma cytokines 
exhibit changes consistent with  the muscle regeneration program, in human volunteers following 
EIMD . Here we present evidence that CEBPB expression is altered with EIMD, and CEBPB expression 
is associated with changes in markers characteristic of inflammatory polarisation. 
 
Methods 
Sixteen healthy, and physically active males (age, x ̅ (±SD) = 43.1 (18.5) years,) undertook 3 sets of 
eccentric loading, 80% 1RM (x ̅(±SD) = 25.4 (5.1) kg, each set to task failure, separated by 2 minutes 
recovery), of the elbow flexors. Eccentric elbow flexion exercise is known to induce structural 
damage in humans [7]The exercise protocol we used is consistent with inflammation in the biceps 
brachii and brachialis muscles [8], maximal voluntary contraction (MVC) was assessed at 60° of 
flexion to allow potentially a greater contribution of damaged brachialis muscle than at 90°. MVC 
was assessed (peak torque, 5 x 3 s isometric contractions / 3 s rest) prior to exercise, and during 
recovery, on an isokinetic dynamometer (Biodex System 3, Biodex Medical Systems Inc., New York). 
This project was approved by the ethics committee of the Department of Sport and Health Sciences, 
University of Exeter. Informed consent forms were signed by participants. Exclusion criteria included 
hypertension, injury, illness, and medications related to inflammation. 
Six millilitres of venous blood was collected into a lithium heparin Vacutainer  (Becton Dickinson, 
USA) and 2.5 ml into a PAXGene blood tube (PreAnalytix GmbH, Hombrechtikon, Switzerland) prior 
to, and 1, 2, 4 and 7 days post exercise. These time-points were chosen to coincide with the M1/M2 
phenotype muscle regeneration model described by Tidball and Villalta [9]. The lithium heparin tube 
was centrifuged for 10 minutes at 4000 RPM, the supernatant was harvested and analysed 
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immediately for creatine kinase activity. The PAXGene tubes were inverted 10 times, incubated at 
room temperature for ~ 3 hours, and stored without separation at -80°C. 
Creatine kinase activity was measured at 37°C using the colorimetric technique described by Szasz 
[10]. Absorbance was recorded at λ 340nm on a Jenway 6300 spectrophotometer (Bibby Scientific 
limited, Staffordshire, UK), and enzymatic activity quantified using a linear regression equation 
derived from a 2-point calibration of known standards. 
Th1 and Th2 cytokines were quantified in plasma by electrochemiluminescence multiplex assay 
(Th1/Th2 10-plex, Meso Scale Discovery, Rockville, MD, USA). Panel of cytokines measured: IFN-γ, IL-
1β, IL-10, IL-12 p70, IL-13, IL-2, IL-4, IL-5, IL-8, and TNF-α. 
RNA extraction using PaxGene blood RNA kit (QIAGEN Ltd., Crawley, UK), and QiaCube automated 
system. mRNA was reverse transcripted to complimentary DNA using Superscript VILO (Applied 
Biosystems, USA) and amplified. cDNA was loaded onto custom TaqMan low density array (TLDA) 
cards on the ABI Prism 7900HT platform (Life Technologies, California, USA). Genes included in the 
study were quantified relative to an endogenous control gene (PPIA). Normalisation to PPIA 
precludes the need to correct for leucocytosis, and has been well validated for its use as an 
appropriate housekeeping gene [11] Samples were amplified in triplicate, over 55 cycles. The 
quantitative value obtained from TaqMan real-time RT-PCR is a threshold cycle (CT). The fold 
differences between time conditions were calculated from the relativized CT values (CT gene X - CT 
housekeeping gene, PPIA), according to the comparative CT method. Genes quantified included 7 
associated with the ‘classical’ inflammatory T1 phenotype and 7 (including CEBPB) with an 
‘alternative’ anti-inflammatory T2 phenotype (Table S1). 
Within-group means were compared by paired t-tests for differences at a priori time points relevant 
to expected outcomes, in particular the rise from baseline to the mean of the subsequent two days, 
during which time M2 polarisation is expected to be induced. Relationships between mRNA 
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expression and circulating cytokine concentrations were explored by Pearson’s correlation 
coefficients. The relationships between blood transcript expression changes and markers of damage 
severity (loss of function and creatine kinase activity) were assessed using robust regression analysis. 
Statistical significance was accepted at p < 0.05. 
 
Results 
Maximal voluntary contraction (MVC, 60° flexion) decreased from baseline, and remained 
significantly depressed throughout the test period (F (1.9, 28.5) = 12.4, p = 1.62 x 10
-4, pairwise 
comparisons, with Bonferroni adjustment, revealed significantly depressed MVC 1 and 4 days post- 
damage fig. 1A). Plasma creatine kinase activity (U/l, at 37°C) increased from baseline , peaking on 
day 4 (F(1.1, 16.7) = 20.1, p = 2.45 x 10
-4, fig. 1B), although only 9 of the 16 subjects showed peak 
increases in creatine kinase exceeding 10,000 U/l.  
There was no significant relationship between basal CEBPB expression and MVC, as observed 
previously. Overall CEBPB gene expression change after exercise (∆ = [day 1 + day 2]/2 – baseline) 
was not significant (F (4,60) = 0.534, p = 0.71). However in the subset whose peak creatine kinase 
activity exceeded 10 000 U/I, CEBPB expression increased from baseline to 2 days post damage (a 
priori paired-samples t(1,8) = 3.72, p = 0.006, Figure 1C), the timeframe anticipated by the model 
described by Tidball & Villalta 2010 [9]. The same change in CEBPB expression was observed in a 
subset of 10 subjects whose 24 hour decrease in MVC decreased > 17 % (t(1,9) = 2.57, p = 0.03). There 
were no overall significant changes post exercise in the selected plasma cytokine concentration 
(table S2) or other transcripts (table S3) and none of these were significant in the high creatine 
kinase subgroup.   
CEBPB gene expression change (∆ = [day 1 + day 2]/2 – baseline) correlated positively with peak 
creatine kinase activity (CK) (fig. 1D, r2 = 0.20, p = 0.007). The % decrease in MVC 1 day post damage 
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induction (a functional assessment of damage severity) was also significantly related to CEBPB 
expression during this time-frame (r2 = 0.11, p = 0.044).  
Supporting the concept that CEBPB changes are related to T Lymphocyte or Macrophage 
differentiation, ∆ CEBPB expression correlated with ∆ IL-1β (r2 = . 701, p = 4.14 x 10-5, fig. 2A), ARG1 
(r2 = . 457, p = .004, fig 2B) and STAT1 (r2 = .402, p = .008) expression. We also observed positive 
correlations between ∆ CEBPB and ∆ plasma INF-γ (r2 = .369, p = .013, fig. 2C), and IL4 concentration 
change (r2 = .29, p = .031, fig. 2C). ∆ = [day 1 + day 2]/2 – baseline. After negative changes in CEBPB 
expression were excluded from the analysis, all the above associations remained significant, except 
for Interleukin 4.  Discussion 
In our previous ageing study, we showed that CEBPB expression in circulating leukocytes correlated 
with muscle strength in older people [6]. We hypothesised that this relationship may reflect the 
reported critical role CEBPB plays in leukocyte mediation of muscle regeneration following injury. 
We anticipated that a single bout of exercise-induced muscle damage would initiate a leukocyte 
governed muscle regeneration response, in which CEBPB expression would provide the essential 
switch between M1 and M2 inflammatory phenotypes. Thus, in a microcosm, we intended to create 
a model to assess the relevance of chronic circulating CEBPB expression, that in future research 
could be applied to the study of age-related functional impairment. Here we present evidence that 
muscle damaging exercise resulted in elevated blood CEBPB expression in volunteers exhibiting 
symptoms of more severe damage (elevated creatine kinase activity and decreased MVC). Although 
the degree of muscle damage was necessarily very small compared to the significant injuries 
explored in laboratory models, we found gene expression with similar direction and timing to those 
seen in models of the Th1/Th2 transition [9]. We also found suggestive evidence that CEBPB 
expression changes post exercise correlated with changes in Th1 and Th2 linked cytokine and 
transcript levels as hypothesised. These findings imply that in the exercise-induced muscle damage 
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model, systemic inflammatory status may play a remote role in the governance of muscle 
remodelling, although more work is needed on this to provide definitive results.  
Since we measured gene transcripts expressed in blood leukocytes, rather than in leukocytes 
resident in damaged muscle, we were challenged to justify our reasoning behind linking CEBPB 
expression to muscle remodelling. Much of the research into immunomodulatory effects on muscle 
regeneration has focused on the actions of resident macrophages. The differentiation of 
macrophages appears to occur in situ in damaged muscle [4], rather than prior to extravasation, and 
whether activated macrophages re-enter the circulation is unclear. Yet there may be a role of 
systemic T lymphocytes, either by influencing myogenesis directly, or by remote macrophage 
phenotype induction [9]. Indeed, CEBPB is involved in the differentiation of TH0 to TH1 and TH2 CD4+ 
cells [12], and the molecular cascade that determines inflammatory phenotype shares similarities 
with that of the macrophage. The relationships between CEBPB and Th1/Th2 markers may support 
this. Circulating IL4 may originate from regenerating muscle [13], known to stimulate CEBPB 
expression involved in M2 macrophage polarity. CEBPB expression is also influenced by IL1b [14], 
suggesting activation from pro-inflammatory leukocytes. We also report a relationship between 
CEBPB and ARG1 expression change; M2 macrophages produce arginase 1 that competes with iNOS 
for L-arginine [5], thereby decreasing the M1 control of myogenic events [15]. In IL4 stimulated 
macrophages, ARG-1 expression is dependent on C/EBP-β-mediated transcription [16]. These 
relationships provide some support that circulating CEBPB expression is related to Th1/Th2 
inflammatory polarity. A role for peripheral factors in age-related muscle regeneration is supported 
by a murine study that infused serum from young mice into old, boosting regeneration capacity [17]. 
Chronic, low grade, systemic inflammation is well known to be related to decreases in muscle mass 
and functional capacity in longitudinal studies of aging [18-20]. Evidence of an anti-inflammatory 
antagonistic effect is sparse, although IL-10 is emerging as a key mediator of macrophage 
inflammatory status, associated with muscle regeneration [21]. As a transcription factor, CEBPB 
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responds to environmental cues, and elevates the production of IL-10, thus acting as an upstream 
mediator of the anti-inflammatory cascade, potentially ameliorating the negative consequences of 
inflammation. Induction of pro-inflammatory mediators of myoblast proliferation is essential for 
optimal muscle regeneration [22], thus CEBPB may possibly be a target for pharmaceutical therapy, 
to facilitate endogenous anti-inflammatory responses.  
This study has several limitations, including a relatively small sample size of 16, limiting statistical 
power. The changes in MVC and creatine kinase suggest that structural damage and inflammation 
occurred in all volunteers, though evidence of inflammatory polarity in circulation was only observed 
in the most severely damaged individuals. The varying severity of damage and the resulting 
disassociation from a universal inflammatory time-course weakened potential main effects. 
Statistical power may be improved in future with the recruitment of a larger sample size, or by 
employing laboratory techniques to improve the resolution of data.  Creatine kinase is a widely used 
but imperfect measure of muscle injury, and follow-up studies could be strengthened by direct 
measures of injury, macrophage infiltration and repair. We did not account for changes in leukocyte 
counts and subsets, but instead observed Th1/Th2 activity via circulatory factors, and normalised 
rather than quantified gene expression. Leukocytosis related to exercise (and/or muscle damage) 
may alter cell- specific contributions to the mixed leukocyte CEBPB expression, which could plausibly 
account for the observed instances of decreased expression during the predicted repair period in the 
current study. Measures of the abundance of specific cell subtypes (especially monocytes and 
macrophages) and gene expression within these cells could have provided more direct evidence 
linking CEBPB expression and macrophage activation. Future work might explore CEBPB and related 
expression after both a first and repeat bouts of exercise, as the latter should attenuate damage.   
In conclusion, CEBPB expression in blood is associated with muscle strength in humans and a 
suggested mechanism for this is that CEBPB expression in macrophages is necessary for repair after 
muscle injury.  We therefore sought to test whether CEBPB expression in blood leukocytes is 
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responsive to muscle injury inducing exercise.  We have shown that in volunteers who sustained 
more severe muscle injury (i.e. those with creatine kinase levels >10,000 U/l) the expected increase 
in CEBPB expression in blood was present 48 hours after exercise. Further study is needed to confirm 
the cellular origin of the CEBPB and related expression changes, and to confirm the mechanistic 
relationship with downstream muscular regeneration events. 
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Figure Legends 
Figure 1. Time-course of muscle injury and relationship with CEBPB. Isometric strength (nm torque, 
± SEM) decreases from baseline (A, *p < .05, n = 16), post- damage. Plasma creatine kinase activity 
(U/l, at 37°C, ± SEM) increases from baseline (B, *p < .05, n = 16) peaking on day 4. CEBPB blood 
transcript expression change (fold change normalised to PPIA mean, ± SEM) in n = 9 subjects with > 
10000 peak plasma creatine kinase activity (C, *p = 0.006). Peak creatine kinase correlates with fold 
change in CEBPB expression (∆T = [day 1 + day 2]/2 – baseline), (D, p = 0.007, n=16). 
Figure 2. CEBPB relationships to mediators of macrophage polarisation. Following exercise-induced 
muscle damage, CEBPB blood transcript expression change shows positive correlations with IL1β (A, 
p = 4.14 x 10-5) and ARG1 (B, p = 0.004) blood transcript expression change, and change in circulating 
INF-γ (C, p = 0.013) and IL-4 concentration in plasma (D, p = 0.031) (∆T = [day 1 + day 2]/2 – baseline, 
n=16). 
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Figure 1 
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Figure 2 
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Supplementary information 
 
Tables 
Table S1. List of genes quantified by RT-PCR. 
mRNA Probe set ID Protein Function Polarity 
ARG1 Hs00163660_m1 Arginase-1 Competes with iNOS M2 
CCL2 Hs00234140_m1 Chemokine (C-C 
motif) ligand 2 
Promotion of M2 macrophages M1 
CEBPB Hs00942496_s1 CCAAT-enhancer-
binding protein 
beta, C/EBP-β 
Transcription factor M2 
polarisation 
M2 
IFNG Hs99999041_m1 Interferon-γ NFκβ1-induced M1 induction M1 
IL10 Hs99999035_m1 Interleukin-10 Th2 produced cytokine promotes 
M2 induction. 
M2 
IL1B Hs01555413_m1 Interleukin-1β Acute-phase inflammatory 
cytokine 
M1 
IL4 Hs00174122_m1 interleukin-4 Activator of M2 differentiation M2 
IL6 Hs00174131_m1 Interleukin-6 Acute-phase inflammatory 
cytokine 
M1 
NFKB1 Hs00231653_m1 Nucleating factor 
κβ 
Transcription factor M1 
polarisation 
M1 
NOS2 Hs01075529_m1 Inducible nitric 
oxide synthase 
NO mediation of inflammation M1 
PPIA Hs99999904_m1 peptidylprolyl 
isomerase A  
Housekeeping gene Neutral 
STAT1 Hs01014002_m1 Signal transducer 
and activator of 
transcription 1 
Monocyte differentiation M1 
STAT6 Hs00598618_m1 Signal transducer 
and activator of 
transcription 6 
Transcription factor, activator of 
IL-4 
M2 
TGFB3 Hs00234245_m1 Transforming 
growth factor β 
Th2 inhibitor of Th1 induction M2 
TNF Hs00174128_m1 Tumor necrosis 
factor-α 
Pro-inflammatory cytokine M1 
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Table S2. Cytokine values, mean (±standard error of the mean) pg/ml. 
Cytokine baseline 1 day 2 day 4 day 7 day 
INF 1.51 (0.38) 1.91 (0.66) 1.73 (0.43) 1.49 (0.31) 1.80 (0.35) 
IL-10 3.85 (0.73) 4.15 (0.95) 3.40 (0.74) 3.84 (0.64) 3.65 (0.42) 
IL-12 0.73 (0.12) 1.13 (0.17) 1.06 (0.21) 1.15 (0.20) 1.13 (0.16) 
IL-13 1.36 (0.36) 2.77 (0.58) 1.75 (0.44) 1.50 (0.45) 2.72 (0.54) 
IL-1b 0.13 (0.04) 0.17 (0.04) 0.10 (0.03) 0.13 (0.04) 0.39 (0.28) 
IL-2 0.52 (0.21) 0.33 (0.05) 0.33 (0.06) 0.50 (0.07) 0.25 (0.05) 
IL-4 0.38 (0.07) 0.58 (0.07) 0.40 (0.10) 0.34 (0.09) 0.27 (0.06) 
IL-5 0.66 (0.13) 0.75 (0.19) 0.60 (0.08) 0.78 (0.11) 0.75 (0.14) 
IL-8 5.42 (0.33) 5.42 (0.28) 4.98 (0.29) 5.33 (0.45) 5.44 (0.29) 
TNF 4.14 (0.28) 4.18 (0.43) 3.93 (0.34) 4.24 (0.31) 3.88 (0.33) 
 
 
 
Table S3. Median expression changes (fold change from baseline, normalised to PPIA)for whole 
leukoctye mRNA. 
 
Day 1 Day 2 Day 5 Day 8 
-ARG1 -0.10673 -0.08279 0.098748 0.131909 
-CCL2 0.126946 0.047975 -0.07423 -0.18606 
-CEBPB 0.076504 0.117974 0.153058 0.131998 
-IFNG -0.23747 0.036396 -0.0905 -0.34527 
-IL10 -0.158 -0.0088 0.099666 -0.02282 
IL1B 0.121334 -0.04249 0.040802 0.082089 
-IL4 0.162821 0.214585 0.105024 0.135871 
-IL6 0.256955 0.356949 2.785703 -2.28549 
-NFKB1 0.084702 -0.03689 0.00857 0.036142 
-NOS2 -0.0224 -0.15965 0.264531 0.572353 
-STAT1 0.039476 -0.01191 0.159687 -0.04803 
-STAT6 0.066525 -0.01228 0.139756 0.061345 
-TGFB3 0.038145 -0.12921 0.052389 0.122875 
-TNF 0.073087 0.006078 0.140433 0.073646 
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